Acceder

Cotización de Revolution Medicines, Inc. (RVMD) hoy en tiempo real

Revolution Medicines, Inc. (RVMD)

Análisis técnico y gráfico histórico de Revolution Medicines, Inc.

Análisis fundamental y estadísticas clave de Revolution Medicines, Inc.

Ficha de Revolution Medicines, Inc. (RVMD)

Ticker RVMD
ISIN US76155X1000
Sector Atención sanitaria
Mercado NASDAQ

Análisis financiero de Revolution Medicines, Inc.

Briefing Valoración Rentabilidad Métricas por acción Deuda Liquidez

Resumen financiero e información corporativa de Revolution Medicines, Inc.

Invertir en Revolution Medicines, Inc. en 2026: Preguntas frecuentes

¿Qué es Revolution Medicines, Inc.?

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhi...

¿En qué sector opera Revolution Medicines, Inc.?

Revolution Medicines, Inc. opera en el sector Healthcare, industria Biotechnology.